In sum, we concluded from these results that an episode of SIRS or sepsis did not compromise the intrinsic ability of CD4+ and CD8+ effector T-cells to respond to cognate antigens on a per cell basis. The gene discussed is CD8A; the disease is systemic inflammatory response syndrome.